Epidemiology and in vitro activity of ceftazidime–avibactam, meropenem–vaborbactam, imipenem–relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates
Sofia Maraki, Viktoria Eirini Mavromanolaki, Eleni Magkafouraki, Panagiotis Moraitis, Dimitra Stafylaki, Anna Kasimati, Effie Scoulica
Topics & Concepts
Ceftazidime/avibactamKlebsiella pneumoniaeColistinBroth microdilutionMicrobiologyMultilocus sequence typingMeropenemAvibactamTigecyclineCarbapenem-resistant enterobacteriaceaeEtestCarbapenemImipenemCeftazidimeMedicineBiologyAntimicrobialMinimum inhibitory concentrationAntibioticsAntibiotic resistanceBacteriaEscherichia coliGenotypePseudomonas aeruginosaGeneticsGeneBiochemistryAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyNosocomial Infections in ICU